Palatin Technologies competitorsClear all

Palatin Technologies's top competitors include Albumedix, Acticor Biotech, Retrophin and GBT (Global Blood Therapeutics).
Palatin Technologies
Palatin Technologies
Palatin Technologies is a biopharmaceutical company, developing targeted, receptor-specific peptide therapeutics for the treatment of various diseases.
Albumedix
Albumedix
Albumedix develops bio-therapeutics formulations for advanced drug and vaccine formulation intended to improve therapies for people with serious diseases.
Acticor Biotech
Acticor Biotech
Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke.
Retrophin
Retrophin
Retrophin is a biopharmaceutical company which focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
GBT (Global Blood Therapeutics)
GBT (Global Blood Therapeutics)
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
Founding Date
Founding Date
1986
Founding Date
2016
Founding Date
2013
Founding Date
2011
Founding Date
2012
Type
Type
Public
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Cranbury Township, US HQ
Locations
Nottinghamshire, GB HQ
Locations
Paris, FR HQ
Paris, FR
Locations
San Diego, US HQ
Dublin, IE
Cambridge, US
Locations
South San Francisco, US HQ
Employees
Employees
185% decrease
Employees
675% increase
Employees
18
Employees
2213% increase
Employees
352106% increase
Valuation ($)
Valuation ($)
123.3 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
1 b
Valuation ($)
3.4 b
Twitter followers
Twitter followers
530
Twitter followers
134
Twitter followers
322
Twitter followers
14
Twitter followers
1.5 k
Alexa Website Rank
Alexa Website Rank
271668
Alexa Website Rank
412348
Alexa Website Rank
257693
Alexa Website Rank
302733
Alexa Website Rank
488148
Employee Rating
Employee Rating
4
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
4.2
Employee Rating
4.8

Financial

Revenue (est.)
Revenue (est.)
$60.3m (FY, 2019)
Revenue (est.)
£26.1m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
$175.3m (FY, 2019)
Revenue (est.)
$2.1m (FY, 2019)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$5.2m (FY, 2019)
Cost of goods
$48k (FY, 2019)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
$170.1m (FY, 2019)
Gross profit
$2.1m (FY, 2019)
Net income
Net income
$35.8m (FY, 2019)
Net income
£5m (FY, 2018)
Net income
N/A
Net income
($146.4m) (FY, 2019)
Net income
($266.8m) (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 104.2m
Total funding raised
N/A
Total funding raised
$ 33.3m
Total funding raised
$ 116m
Total funding raised
$ 88.7m
For sources of this data, please see the company profile

View company profiles

Albumedix
HQ
Nottinghamshire, GB
Employees
67↑ 5% increase

Albumedix develops bio-therapeutics formulations for advanced drug and vaccine formulation intended to improve therapies for people with serious diseases.

View company
Acticor Biotech
HQ
Paris, FR
Employees
18

Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke.

View company
Retrophin
HQ
San Diego, US
Employees
221↑ 3% increase

Retrophin is a biopharmaceutical company which focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.

View company
GBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352

GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.

View company